Dr Reddys Laboratories (RDY) Non-Current Debt (2009 - 2026)
Dr Reddys Laboratories (RDY) posted quarterly Non-Current Debt of $130.0 million for Q1 2026, up 41.3% year-over-year from $92.0 million in Q1 2025, and up 41.3% quarter-over-quarter from $92.0 million in Q1 2025.
Dr Reddys Laboratories (RDY) Non-Current Debt (2009 - 2026) Analysis & Trends
Dr Reddys Laboratories' Non-Current Debt history runs 10 years deep, the most recent figure standing at $130.0 million for Q1 2026.
- In Q1 2026, Non-Current Debt rose 41.3% year-over-year to $130.0 million; the TTM figure through Mar 2026 stood at $130.0 million (up 41.3% YoY), while the FY2026 annual figure was $130.0 million, up 41.3% from the prior year.
- Non-Current Debt for Q1 2026 stood at $130.0 million, up from $92.0 million in the prior quarter.
- The five-year high for Non-Current Debt was $130.0 million in Q1 2026, with the low at $16.0 million in Q1 2023.
- The 5-year median for Non-Current Debt is $76.0 million (2022), against an average of $77.2 million.
- The sharpest annual moves came in 2023 and 2024: Non-Current Debt plunged 78.95% in 2023, then jumped 350.0% in 2024.
- Dr Reddys Laboratories' Non-Current Debt stood at $76.0 million in 2022, then slumped by 78.95% to $16.0 million in 2023, then surged by 350.0% to $72.0 million in 2024, then increased by 27.78% to $92.0 million in 2025, then soared by 41.3% to $130.0 million in 2026.
- Business Quant data shows RDY's Non-Current Debt at $130.0 million in Q1 2026, $92.0 million in Q1 2025, and $72.0 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 130.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 1.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 130.00 Mn |
| Mar 31, 2025 | 92.00 Mn |
| Mar 31, 2024 | 72.00 Mn |
| Mar 31, 2023 | 16.00 Mn |
| Mar 31, 2022 | 76.00 Mn |
| Mar 31, 2021 | 86.00 Mn |
| Mar 31, 2020 | 17.00 Mn |
| Mar 31, 2019 | 318.00 Mn |
| Mar 31, 2018 | 385.00 Mn |
| Dec 31, 2009 | 150.00 Mn |
| Sep 30, 2009 | 174.00 Mn |
| Jun 30, 2009 | 191.00 Mn |